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Abstract
Background: For the majority of patients with osteoarthritis (OA), joint replacement is a successful
intervention for relieving chronic joint pain. However, between 10-30% of patients continue to experience
chronic pain after joint replacement. Evidence suggests that a risk factor for chronic pain after joint
replacement is the severity of acute post-operative pain. The aim of this randomised controlled trial (RCT) is
to determine if intra-operative local anaesthethic wound infiltration additional to a standard anaethesia
regimen can reduce the severity of joint pain at 12-months after total knee replacement (TKR) and total hip
replacement (THR) for OA.
Methods: 300 TKR patients and 300 THR patients are being recruited into this single-centre double-blind
RCT. Participants are recruited before surgery and randomised to either the standard care group or the
intervention group. Participants and outcome assessors are blind to treatment allocation throughout the
study. The intervention consists of an intra-operative local anaesthetic wound infiltration, consisting of 60
mls of 0.25% bupivacaine with 1 in 200,000 adrenaline. Participants are assessed on the first 5 days post-
operative, and then at 3-months, 6-months and 12-months. The primary outcome is the WOMAC Pain Scale,
a validated measure of joint pain at 12-months. Secondary outcomes include pain severity during the in-
patient stay, post-operative nausea and vomiting, satisfaction with pain relief, length of hospital stay, joint
pain and disability, pain sensitivity, complications and cost-effectiveness. A nested qualitative study within
the RCT will examine the acceptability and feasibility of the intervention for both patients and healthcare
professionals.
Discussion: Large-scale RCTs assessing the effectiveness of a surgical intervention are uncommon, particulary in
orthopaedics. The results from this trial will inform evidence-based recommendations for both short-term and
long-term pain management after lower limb joint replacement. If a local anaesthetic wound infiltration is found to
be an effective and cost-effective intervention, implementation into clinical practice could improve long-term pain
outcomes for patients undergoing lower limb joint replacement.
Trial registration: Current Controlled Trials ISRCTN96095682
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Joint replacement is one of the most common elective
surgical procedures, with over 150,000 total hip replace-
ments (THR) and total knee replacements (TKR) per-
formed annually in England and Wales in the National
Health Service (NHS) [1]. Although chronic pain is the
main indication for joint replacement, it is also a com-
mon occurrence after surgery. Studies have estimated
the incidence of chronic pain after joint replacement to
be in the region of 10-30% [2-4]. Chronic pain after sur-
gery is defined by the International Association for the
Study of Pain (IASP) as pain that develops after a surgi-
cal intervention and is of at least 3-months duration [5].
Chronic pain is a widely-observed phenomenon after
many surgical procedures including breast surgery [6],
inguinal hernia repair [7] and thoracic surgery [8].
Research evidence suggests that an important risk factor
for chronic pain after surgery is the severity of acute
post-operative pain [9,10]. Therefore, in addition to
causing unnecessary distress and discomfort during the
post-operative period, poorly managed post-operative
pain can have negative consequences for long-term sur-
gical outcomes. Adequate management of post-operative
pain still poses a significant challenge to healthcare, as
demonstrated by a review of the literature which con-
cluded that 30% of patients experience moderate or
severe pain after surgery [11]. In a recent study at the
Avon Orthopaedic Centre, 58% of TKR patients and
47% of THR patients reported moderate or severe pain
on the first post-operative day [12]. Therefore, there is a
need for trials of interventions targeting acute post-
operative pain with the ultimate aim of improving long-
term outcomes after joint replacement.
In the context of joint replacement, post-operative pain
management needs to provide effective pain relief, while
allowing for early mobilisation and rehabilitation [13].
Although many of the traditional methods of achieving
peri-operative pain relief can hinder early mobilisation
[14], a review of the use of multimodal analgesia in differ-
ent conditions found that a combination of systemic
opioids, nonsteroidal anti-inflammatory drugs, and epi-
dural analgesics or wound infiltration can provide effec-
tive pain control and improve post-operative recovery
[15]. In joint replacement, there is evidence that multi-
modal analgesia can give good pain relief with minimal
side effects [16,17]. A systematic review of a wide range
of surgical procedures concluded that the use of local
anaesthetic wound infiltration as part of a multimodal
approach reduced post-operative pain, opioid use, nausea
and vomiting, improved patient satisfaction and reduced
the length of hospital stay [18]. Fifteen randomised con-
trolled trials (RCT) in joint replacement identified up to
August 2010 are described in Table 1 [19-33]. The results
from these studies found that short-term outcomes after
joint replacement using multimodal analgesia were
broadly favourable. However, with only one small study
reporting outcomes after six months, there is little evi-
dence on longer-term pain outcome.
T h ee x i s t i n gl i t e r a t u r ep r o v i d e se v i d e n c et h a tt h eu s e
of local anaesthetic wound infiltration as part of a multi-
modal anaesthetic regimen reduces short-term post-
operative pain after joint replacement. However, it is
not known if the reduction of this short-term post-
operative pain reduces the severity of chronic pain. The
aim of this RCT is to determine if using intra-operative
local anaesthetic wound infiltration significantly reduces
the severity of joint pain at 12-months after primary
TKR or THR.
Methods
The Arthroplasty Pain Experience (APEX) study is a sin-
gle-centre double-blind RCT that is currently being con-
ducted at the Avon Orthopaedic Centre, one of the
largest orthopaedic centres in the UK. The study has
been approved by Southampton and South West Hamp-
shire Research Ethics Committee (B) (09/H0504/94) and
all participants provide informed, written consent. The
trial has been registered with EudraCT (2009-013817-
93) and Current Controlled Trials (ISRCTN96095682).
The trial is also registered as a Clinical Trial of a Inves-
tigational Medicinal Produce with the Medicine Health-
care and Regulary Authority (18524/0215/001-0001).
Study duration
Recruitment into the trial began in November 2009 and
12-month follow-up for all participants is anticipated to
be complete by November 2012.
Participant recruitment
Potential participants are screened and recruited by
research nurses from pre-operative assessment clinics at
the Avon Orthopaedic Centre. Inclusion criteria include
being listed for a primary unilateral TKR or THR for
osteoarthritis (OA) and being willing and able to provide
fully-informed consent. Exclusion criteria include i.) any
medical co-morbidity that precludes spinal anaesthesia,
regional blocks or the use of strong analgesics post-
operatively ii.) severe dementia or psychiatric illness
such that they are unable to complete the questionnaires
or provide informed consent iii.) listed for simultaneous
bilateral joint replacement iv.) having been in the APEX
trial for a previous joint replacement v.) being unable to
understand English as not all the questionnaires have
been translated and validated into other languages. In
order to explore generalisability (the patients enrolled in
the study being representative of those undergoing joint
replacement) anonymised data about age and gender is
recorded for all eligible patients.
Wylde et al. BMC Musculoskeletal Disorders 2011, 12:53
http://www.biomedcentral.com/1471-2474/12/53
Page 2 of 10Table 1 Randomised controlled trials of local anaesthetic wound infiltration in hip or knee joint replacement
Author Study design
Patients
Longest follow
up
Common treatment Results
Intervention Control
Bianconi
2003 [20]
Italy
RCT
TJR
N=3 7
72 hours
Spinal anaesthsia with bipuvicaine and a loading dose of intravenous
morphine 10 mg. Intravenous infusion of normal saline at the same
rate for 24 hours
VAS pain at rest and on mobilisation
significantly reduced in the intervention
group up to 72 hours. Use of diclofenac and
tramadol lower in the intervention group,
and length of hospital stay reduced. Patient
satisfaction greater in the intervention
group.
Wound infiltration with ropivacaine solution
followed by wound perfusion for 55 hours
Baseline intra-venous
infusion of morphine
plus ketorolac for
24 hours
Toftdahl
2007 [21]
Sweden
RCT
TKR
N=8 0
24 hours
Spinal anaesthesia and controlled release oxycodon Intervention group had a quicker recovery,
lower pain scores, and lower use of opioids.
There was no difference in side effects or
length of hospital stay.
Peri- and intraarticular infiltration and
injection
Continuous femoral
nerve block
Andersen
2007 [22]
Denmark
RCT
THR
N=8 0
Until discharge
Spinal anaesthesia Pain reduced in intervention group. Narcotic
consumption was reduced and the length
of hospital stay was shorter.
Wound infiltration and intraarticular
injection of local anaesthetic
Epidural infusion
Andersen
2007 [23]
Denmark
RCT
THR
N=4 0
6 weeks
Spinal anaesthesia Patients who received the active wound
infiltration had less pain for up to 2 weeks.
They reached an earlier and lower pain
minimum during the first days post-
operatively, had lower use of analgesia up
to day 4 post-operatively, and were more
satisfied. Use of analgesic solution resulted
in less joint stiffness and better function
1 week postoperatively. No significant
benefit at 6 weeks.
Wound infiltration with ropivacaine,
ketorolac, and adrenaline at the end of
surgery and through an intraarticular
catheter 24 hours post-operatively
Saline infiltration
Vendittoli
2006 [33]
Canada
RCT
TKR
N=4 2
24 hours
Spinal anaesthesia and patient controlled morphine Morphine use and the incidence of nausea
was significantly lower in the intervention
group.
Perioperative infiltration of local anesthetic
Busch
2006 [25]
Canada
RCT
TKR
N=6 4
6 weeks
Spinal anaesthesia and patient controlled morphine Patient-controlled analgesia use was
reduced in the 24 hours after surgery in the
intervention group. VAS pain scores also
improved in the intervention group after
the operation. No significant benefit at
6 weeks.
Locally injected anaesthetic
Andersen
2008 [29]
Denmark
Individual patient
knees randomised
to
intervention or
control.
TKR (bilateral)
N=1 2
48 hours
Spinal anaesthesia and patient controlled morphine Pain at rest and during movement
significantly reduced for up to 32 hrs in the
intervention group.
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(Continued)
Infiltration with ropivacaine and
epinephrine. Further intra-articular injections
through catheter over 24 hours.
Similar procedures
with saline.
Essving
2009 [32]
Sweden
RCT
Unicompartmental
knee arthroplasty
N=4 0
6 months
General anaesthesia and patient controlled Essving morphine Hospital stay shorter in intervention group.
Post-operative pain lower at rest during
27 hr in-hospital follow up. Morphine
consumption lower for the first 48 hr in
intervention group. Also lower frequency of
nausea, pruritus, and sedation. No benefit in
Oxford knee score and EQ-5 D in
intervention group at 3 or 6 months.
Periarticular infiltration of ropivacaine,
ketorolac and epinephrine. Further injection
through catheter at 21 hrs.
Similar volume of
saline injected via
catheter
Fu
2009 [19]
China
RCT
TKR
N=8 0
15 days (pain)
Spinal anaesthesia and patient controlled morphine Significant reduction in morphine
consumption. VAS pain at rest and activity
improved up to 36 hours. No difference in
VAS pain from 48 hours.
Intraoperative intra-articular injection and
infiltration of morphine, bupivacaine and
betamethasone
Similar procedure with
saline
Parvataneni
2007 [30]
USA
RCT
TKR
N=6 0
3 months
Spinal anaesthesia with or without femoral nerve block Non-significant reduction in VAS pain and
greater satisfaction in intervention group on
day 1 but later VAS pain and satisfaction
were similar. Narcotic consumption was
reduced in the intervention group. The
intervention was associated with quicker
functional recovery but length of hospital
stay was similar between the groups.
Local periarticular injection of bupivacaine,
morphine sulfate, epinephrine,
methylprednisolone acetate, cefuroxime
Patient controlled
analgesia (ketoralac
and, if ineffective,
morphine)
Parvataneni
2007 [30]
USA
RCT
THR
N=7 1
3 months
Spinal anaesthesia with or without femoral nerve block VAS pain reduced in intervention group at 3
days but similar at 6 weeks and 3 months.
Satisfaction greater in hospital in
intervention group but similar at 6 weeks
and 3 months. Lower narcotic use in
intervention group. Functional recovery was
quicker and the hospital stay shorter in the
intervention group.
Local periarticular injection of bupivacaine,
morphine sulfate, epinephrine,
methylprednisolone acetate, cefuroxime
Patient controlled
analgesia (ketoralac
and, if ineffective,
morphine)
Zhang
2007 [31]
China
RCT
TKR
N=6 0
72 hours
Patient controlled analgesia VAS pain at rest and on activity reduced in
intervention group until 24 hours. No
difference at 36-72 hours. Reduced post-
operative tramadol use in intervention
group. Range of motion improved in
intervention group at 72 hours.
Intraoperative periarticular injection of
bupivacaine, epinephrine and morphine
No drug infiltration
Gomez-
Cardero
2010 [26]
Spain
RCT
TKR
N=5 0
1 month
Spinal anaesthesia Cardero Pain intensity and opiod use in the first
3 days post-operative were reduced in the
intervention group. Length of hospital stay
was lower in the intervention group. There
was no difference in pain intensity at
1- month post-operative.
Continous intraarticular infusion with
ropivacaine
Saline infusion
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Before participants undergo surgery, they are rando-
mised to either the standard care group or the interven-
tion group. Randomisation is conducted by means of a
computer-generated code, administered centrally and
communicated via the internet (through the Bristol Ran-
domised Trials Collaboration). Randomisation is strati-
fied by operation site (TKR/THR) and minimised by
baseline joint pain severity and surgical approach. The
operating surgeon and anaesthetist are blind to the
results of randomisation until the beginning of the
operation, when they are informed of treatment alloca-
tion by a member of the research team who is not
involved in outcomes assessment. The study partici-
pants, research nurses involved in recruitment and
assessment, and clinical staff involved in the care of
study participants are blind to treatment allocation
throughout the study.
Intervention
Hip replacement participants
Standard care group The standard anaesthetic care for
THR participants is a spinal anaesthetic with 3 mls of
0.5% plain bupivacaine placed at the L3,4 or L4,5 inter-
space. Intra-operatively, the patient is either awake,
sedated or under a light general anaesthetic, depending
on patient and anaesthetic factors. If there is intra-
operative discomfort then rescue analgesia in the form
of intravenous fentanyl is titrated to effect. All partici-
pants are given 1 g of intravenous paracetamol 30 min-
utes before the end of the operation. In the recovery
area immediately post-operative, participants receive (if
no contra-indications are present) 400 mg of ibuprofen
administered orally. A patient controlled analgesia
(PCA) device is started containing morphine 1 mg/ml, a
1 mg bolus dose and a 5 minute lock-out. If on awaken-
ing the patient is in pain with a rating of more than
50 mm on a 100 mm pain visual analogue scale (VAS),
a morphine bolus up to 0.2 mg/kg can be administered
as rescue analgesia.
Each day during their hospital stay, participants receive
a visit from a pain specialist nurse. Post-operative analge-
sia consists of oral or intravenous paracetamol every
6 hours and, if no contraindications are present, oral ibu-
profen 400 mg every 8 hours. When the PCA is no longer
needed, oral codeine phosphate 30-60 mg every 6 hours,
tramadol 50-100 mg every 6 hours and oramorph
10-20 mg are prescribed as rescue analgesia.
Intervention group The intervention group receives the
same anaesthetic and analgesic regime as the standard
care group, plus an intra-operative local anaesthetic
wound infiltration. The local anaesthetic mixture con-
s i s t so f6 0m l so f0 . 2 5 %b u p i v a c a i n ew i t h1i n2 0 0 , 0 0 0
adrenaline. If the patient is below 60 kg or particularly
frail, the volume of injectate is reduced to 50 mls or
lower if necessary. The surgeon injects the anaesthetic
mixture into the joint capsule and short external rota-
tors, fascia, fat and subcutaneous tissue.
Knee replacement participants
Standard care group The standard anaesthetic care for
TKR participants is a femoral nerve block and a spinal or
general anaesthetic, depending on patient factors. The
femoral nerve blockade is achieved by an injection of
20 mls of 0.25% bupivacaine sited with the use of a nerve
stimulator and/or ultrasound guidance. Intra-operative
analgesia is provided by titration of intravenous fentanyl
Table 1 Randomised controlled trials of local anaesthetic wound infiltration in hip or knee joint replacement
(Continued)
Essving
2010 [27]
Sweden
RCT
TKR
N=4 8
3 months
General anaesthesia and patient controlled morphine Morphine consumption and pain intensity
on movement was reduced in the
intervention group in the first 48 hours
post-operative. Patient satisfaction was
higher in the intervention group. Length of
stay was not affected and no significant
benefit was evident at 3-months post-
operative.
Intraarticular injection of ropivacaine,
ketorolac and epinephrine during surgery
and through a catheter at 21 hours post-
operatively
No injection during
surgery and saline
injection at 21 hours
post-operatively
Chen
2010 [28]
Taiwan
RCT
THR
N=9 2
Discharge
General anaesthesia Intervention group had a longer mean time
to first narcotic rescue, but there was no
difference in pain relief, narcotic use or
length of stay.
Continous intra-articular infusion of
bupivacaine via a infusion pump for 48
hours
Continous intra-
articular infusion of
saline via a infusion
pump for 48 hours
RCT = randomised controlled trial, TKR = total knee replacement, THR = total hip replacement, TJR = total joint replacement.
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achieve haemodynamic stability and a smooth emer-
gence. All participants are given 1 g of intravenous para-
cetamol 30 minutes before the end of the operation. The
post-operative pain management regime for TKR partici-
pants is the same as that described for THR participants.
Intervention group The intervention group receive the
same anaesthetic and analgesic regime as the standard
care group, plus an intra-operative local anaesthetic
wound infiltration. The local anaesthetic mixture is the
same as described for THR participants. The surgeon
injects the anaesthetic mixture into the posterior cap-
sule, medial and lateral capsule, fascia and muscle, and
subcutaneous tissues.
Assessment times
Participants are followed-up for 12-months after sur-
gery. Assessments are conducted pre-operatively, daily
during the hopsital stay, and then at 3-months, 6-
months and 12-months post-operative. Outcomes are
assessed using self-report questionnaires, joint examina-
tions, analysis of x-rays, pressure algometry and extrac-
tion of data from hospital records.
Primary outcome measure
The primary outcome is the 12-month Western Ontario
and McMaster Universities Index of Osteoarthritis
(WOMAC) Pain Scale [34]. The WOMAC Pain score is
a widely-used and validated questionnaire to assess the
severity of joint pain in OA patients [35]. The severity
of joint pain is assessed when performing 5 different
activities: walking, using stairs, sitting or lying, standing
upright and in bed. Response options for each item are
on a 5-point ordered response scale, ranging from none
to extreme, which are summed and then transformed
into a 0-100 scale (extreme pain-no pain).
Secondary outcome measures
Pain severity during the in-patient stay
On the day of surgery, participants are asked to verbally
rate their pain severity on a 0-10 scale when they wake
up in the recovery room and when they leave recovery,
and then on a 4-hourly basis when they are transfeered
to a ward. From the day after surgery to discharge (or
up to post-operative day 5), participants complete a
100 mm VAS for pain severity at rest and 100 mm VAS
for pain severity on movement in the morning, after-
noon and evening.
Satisfaction with in-patient pain relief
At the end of each day, participants complete a 100 mm
VAS to indicate their satisfaction with their pain relief.
Nausea and vomiting during the in-patient stay
Participants are asked whether they have experienced
any vomiting or nausea (yes/no variable) each day. If
participants have experienced nausea, they then indicate
how distressing it was on a 100 mm VAS (not at all dis-
tressing to very distressing).
Length of hospital stay
This is calculated from participants admission and dis-
charge dates.
Joint pain and disability
The WOMAC [34] and the Intermittent and Constant
Osteoarthritis Pain (ICOAP) [36] are completed
pre-operatively, and then at 3-months, 6-months and
12-months post-operatively. To assess whether the
intervention reduces the incidence of chronic neuro-
pathic pain, participants complete the PainDETECT-
questionnaire [37] at 12-months post-operative.
Pressure algometry
Pressure pain thresholds, which are a measure of pain
sensitivity, are measured on the volar forearm before
surgery, on discharge from hospital, and 12-month post-
operative using a pressure algometer (Somedic, Sweden).
Medical and surgical complications
This data is recorded from hospital records during the
in-patient stay, a telephone call to participants at 3-
months post-operative, and a comprehensive joint
assessment by a research nurse and an x-ray review at
12-months post-operative. If participants report the
occurence of a complication at either 3-months of 12-
months post-operative, this is verified by a review of
their hospital records.
Cost effectiveness
Health service resource data, including staff time and
other resources used in the intervention, subsequent
inpatient stays, outpatient and community based visits
and medication are collected using hospital records and
participant self-complete questionnaires. These ques-
tionnaires also collect information on social service use,
travel, time off work, usual activities, informal care, and
include the EQ-5D [38].
Potential prognostic factors
A number of possible potential prognostic factors are
also being recorded, including socio-demographic fac-
tors, medical comorbidities, structural joint damage,
health-related quality of life and psychosocial factors.
The EQ-5D [38] is being used as a measure of health-
related quality of life and the following questionnaires
are being used to assess psychosocial factors: Hospital
Anxiety and Depression Scale [39], Pain Self-Efficacy
questionnaire [40], Illness Perceptions Questionnaire-
Revised [41] and the Brief COPE [42].
Nested qualitative study
Within the RCT, there is a nested qualitative study to
explore the acceptability and feasibility of the interven-
tion for both patients and healthcare professionals.
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include a range of socio-demographic variables so they
adequately reflect those of a range of NHS patients
undergoing joint replacement and NHS staff involved in
joint replacement surgery. Data collection comprises of
in-depth qualitative interviews with up to 25 patients at
2-3 weeks post-operative and with up to 20 healthcare
professionals involved in the trial. Interviews with
patients elicit experiences of surgery and post-operative
recovery, acceptability of their treatment, identify infor-
mation needs regarding anaesthesia and the degree to
which they would like to be involved in decision-making
about pain management. Interviews with healthcare pro-
fessionals explore the acceptability and feasibility of the
intervention and identify any potential barriers to the
implementation of the intervention. The interviews are
audio-recorded and fully transcribed, and themes are
compared within and between one another using con-
stant comparison techniques [43].
Sample size calculation
The primary outcome for this trial is the WOMAC Pain
score at 12-months post-operative. The trial is powered
to allow the THR and TKR groups to be analysed sepa-
rately. Three hundred patients listed for TKR are being
recruited into the study, and 150 patients will be rando-
mised to the intervention arm and 150 to the standard
care arm. The same number of patients listed for THR
are being recruited and randomised. This sample size
will provide 90% power to detect a difference of 0.5
standard deviations on the WOMAC Pain Scale with a
two-sided 1% significance level, and allows for a 20%
dropout rate. Previous research suggests standard devia-
tions of around 17 mm on the WOMAC Pain Scale
before surgery [44]. Hence a difference between the
treatment groups of 0.5 standard deviations equates to a
difference of approximately 8-9 units on the WOMAC
Pain Scale (0-100 scale).
Statistical analysis
In terms of generalisability, the characteristics of those
successfully recruited into the trial will be compared
with those who were eligible but declined to participate.
A CONSORT diagram [45] will summarise participant
flow through the study, documenting invitation and
recruitment, receipt of intervention or standard care as
allocated, and collection of data. To check for balance
between the groups, participants in the intervention and
standard care arms will be described separately in terms
of demographic, stratification/minimisation variables,
and baseline measures. The percentage of participants
not providing primary and secondary outcome data at
each of the follow-up stages will be reported for each
trial arm. Factors associated with missing data (such as
demographics and values of primary and important sec-
ondary outcome variables at baseline) will be explored.
Analysis will consider TKR and THR separately. The
primary analysis will be implemented using a multivari-
able generalised linear model to investigate between-
group differences in mean WOMAC pain score at 12
months follow-up, adjusting for minimisation variables
and baseline value of the primary outcome. The type of
model will depend on the distribution of the WOMAC
pain score data. The primary analysis will be conducted
on an intention-to-treat (ITT) basis without imputation.
However, sensitivity analyses will inform the interpreta-
tion of the primary analysis. These will include an esti-
mate of between-group difference for the primary
outcome using a per-protocol analysis. In addition, the
effect of missing primary outcome data will be investi-
gated using multiple imputation methods and random
effects regression models will be used to investigate any
clustering of outcomes by surgeon.
The same general approach will be followed for analy-
sis of secondary outcome measures. For additional
exploratory analyses, data will be considered within each
treatment group separately and so treated as two cohort
studies. Analyses will examine the impact of potential
risk factors, specified a priori (see section on potential
prognostic factors), on pain severity at 12-months post-
operative independent of any treatment effects.
Health economic analysis
The aim of the economic evaluation is to compare from
a societal perspective the costs and effects of the inter-
vention compared to standard care. Resource use in
relation to joint replacement is collected from the date
of operation until the end of the trial. Health service
resource use is valued using the hospital finance depart-
ment data, as well as routine UK data sources. Patient
and informal carer resource use is valued using self-
report and routine data sources. The analysis will con-
sider TKR and THR participants separately. The analysis
will first estimate the between group differences in
mean costs using bootstrapping techniques to obtain
bias corrected confidence intervals if the data are
skewed. Then, incremental cost effectiveness between
the two arms of the trial will be estimated using the
WOMAC Pain score and the EQ-5 D to calculate Qual-
ity Adjusted Life Years (QALYs) for this population dur-
ing the trial period. These results will be presented as
incremental cost-effectiveness ratios and cost-effective-
ness acceptability curves, derived used bootstrapping
techniques. These will show the probability of the inter-
vention being cost-effective at a range of ‘willingness to
pay’ threshold levels.
The net monetary benefit statistic, using the difference
in costs and the difference in QALYs between the two
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values of the societal willingness to pay for a year of life.
In addition, because of the number of important sec-
ondary outcomes, a cost consequence analysis will be
conducted in which the difference in costs and the dif-
ference in effects between the two arms of the trial are
presented in tabular form. Sensitivity analysis will then
be conducted to take account of uncertainty and impre-
cision in measurements, and will include multiple impu-
tation models for missing values. All these analyses will
be on an ITT basis and will adjust for minimisation
variables.
Discussion
Many people experience chronic pain after a range of
different surgical procedures [2-4,6-8], and this pain is
often accompanied by considerable psychological dis-
tress [46]. For patients undergoing joint replacement,
chronic pain can be particularly distressing because the
main reason for electing to undergo surgery is to gain
relief from chronic joint pain. Therefore, for the 10-30%
[2-4] of patients who experience severe chronic pain
after joint replacement, the surgery has been unsucessful
in achieving its primary aim. The number of patients
who develop chronic pain after joint replacement will
continue to increase as the need for joint replacement
increases [47], and therefore it is important that inter-
ventions to optimise outcomes after joint replacement
are evaluated.
RCTs are the highest level of evidence to assess the
effectivness of a surgical intervention. However, there is
a paucity of well-designed and sufficiently-powered
RCTs of surgical interventions, particulary within ortho-
paedics. Common problems with the design and report-
ing of orthopaedic-based RCTs include patients and
outcome assessors not being blinded to treatment allo-
cation, use of unvalidated or modified validated outcome
measures, no sample size calculation being performed
prior to the trial, unclear inclusion and exclusion cri-
teria, and lack of information on the method of statisti-
cal analysis [48-51]. The APEX trial overcomes these
limitations, as demonstrated by its prospective double-
blind randomised design, use of a validated primary out-
come measure, sufficient statistical power to detect a
clinically meaningful reduction in long-term pain sever-
ity, and clearly defined methods of analysis. In addition,
the APEX trial benefits from the inclusion of a cost-
effectiveness analysis and a nested qualitative study to
assess the acceptability and feasibility of trial participa-
tion and of the intervention.
The primary aim of the APEX trial is to determine if
the addition of an intra-operative local anaesthetic
wound infiltration to the standard anaesthetic regime at
the Avon Orthopaedic Centre can significantly reduce
the severity of joint pain at 12-months after primary
THR and TKR. The results from this trial will inform
evidence-based recommendations for both short-term
and long-term pain management after lower limb joint
replacement. If a local wound infiltration is found to be
an effective and cost-effective intervention, its imple-
mentation into clinical practice could reduce the severity
of chronic pain after THR and TKR, and therefore
improve long-term pain outcomes for patients under-
going lower limb joint replacement.
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